Tower Research Capital (TRC)’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.6K Buy
17,518
+7,078
+68% +$14.8K ﹤0.01% 3234
2025
Q1
$17.8K Buy
10,440
+7,599
+267% +$13K ﹤0.01% 3089
2024
Q4
$14.3K Sell
2,841
-12,006
-81% -$60.6K ﹤0.01% 3465
2024
Q3
$80.8K Sell
14,847
-13,065
-47% -$71.1K ﹤0.01% 2398
2024
Q2
$134K Buy
27,912
+22,217
+390% +$107K ﹤0.01% 2371
2024
Q1
$17.7K Sell
5,695
-3,294
-37% -$10.2K ﹤0.01% 3104
2023
Q4
$25.5K Buy
8,989
+6,504
+262% +$18.5K ﹤0.01% 3507
2023
Q3
$7.28K Sell
2,485
-8,961
-78% -$26.3K ﹤0.01% 4483
2023
Q2
$32.7K Buy
11,446
+6,821
+147% +$19.5K ﹤0.01% 2925
2023
Q1
$14K Buy
4,625
+80
+2% +$242 ﹤0.01% 3886
2022
Q4
$9K Buy
4,545
+557
+14% +$1.1K ﹤0.01% 4203
2022
Q3
$13K Sell
3,988
-2,707
-40% -$8.82K ﹤0.01% 4269
2022
Q2
$21K Buy
6,695
+2,516
+60% +$7.89K ﹤0.01% 3740
2022
Q1
$30K Sell
4,179
-381
-8% -$2.74K ﹤0.01% 3148
2021
Q4
$33K Buy
+4,560
New +$33K ﹤0.01% 3130